WHOOP’s $10.1 billion valuation, backed by sovereign wealth funds and star athletes, signals a major push to turn personal fitness data into a global health utility.
Back
WHOOP’s $10.1 billion valuation, backed by sovereign wealth funds and star athletes, signals a major push to turn personal fitness data into a global health utility.

Human performance company WHOOP raised $575 million in a Series G funding round, achieving a $10.1 billion valuation that advances its global expansion and focus on personalized health. The financing, led by Collaborative Fund, includes significant investments from sovereign wealth funds and global athletes, positioning the company to scale its subscription-based health platform.
"Our raise brings together the world’s most sophisticated investors, leading health institutions, and iconic global athletes behind the mission to unlock human performance and healthspan," said Will Ahmed, Founder and CEO of WHOOP. "We are building the personal health platform that people use to improve their health and livelihood."
The round boosts WHOOP’s total capital raised to over $900 million and comes after a period of rapid growth, with the company reporting 103 percent year-over-year bookings growth in 2025 and exiting the year with a $1.1 billion revenue run rate. The company, which now has over 2.5 million members, was also cash-flow positive in 2025. Key investors include Qatar Investment Authority (QIA), Mubadala Investment Company, and healthcare giant Abbott.
This new capital infusion provides WHOOP the firepower to accelerate its challenge against tech giants like Apple and Google in the wearables market. The funding is earmarked for international growth and scaling its platform, which is shifting from fitness tracking toward preventative health with features like an FDA-cleared ECG and blood biomarker analysis, indicating a strategic pivot to the higher-margin health-tech sector.
A significant portion of the proceeds will fuel expansion across the Gulf Cooperation Council (GCC), Europe, Latin America, and Asia. The participation of QIA, Mubadala, and Abu Dhabi-based 2PointZero Group shows a clear strategic focus on the Middle East. As part of this initiative, WHOOP will open WHOOP Labs Doha in Qatar, its first international performance research and development facility.
The investment from athletes like Cristiano Ronaldo, LeBron James, and Rory McIlroy, who are also users of the device, reinforces the brand's connection to elite performance. "WHOOP has become one of the most important tools I use to support my long-term health," said Cristiano Ronaldo, who joins as a global ambassador. This contrasts with competitors like Apple Watch and Google's Fitbit, which have a broader consumer focus. WHOOP’s subscription model, which includes the hardware with a membership starting at $239 annually, creates a recurring revenue stream that is attractive to investors, justifying its valuation, which far exceeds the $1.6 billion valuation of its direct competitor, Oura, in its last funding round.
With this financing, WHOOP plans to hire for over 600 new roles to support its expansion. The strategic partnership with Abbott, a global healthcare leader, further signals WHOOP's ambition to integrate more deeply into the clinical health landscape, moving beyond general wellness to become an essential tool for preventative care and healthspan extension.
This article is for informational purposes only and does not constitute investment advice.